Catalys Pacific Fund, LP

13D and 13G Filings

13D/G filings
13G on 1 security
Location
Fujisawa, Kanagawa, Japan
CIK
0001746274
Alternate names
Bioventure Creation Fund, L.P.
Form D filings
3 filings
All SEC filings
View on sec.gov
Issuer % of Class Filed
Mineralys Therapeutics, Inc. 13G/A Amendment 3
MLYS · 603170101
10.1% 2/13/2026
Event 12/31/2025
Mineralys Therapeutics, Inc. 13G/A Amendment 2
MLYS · 603170101
13.5% 8/14/2025
Event 6/30/2025

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.